Body dysmorphic disorder and depression: Theoretical considerations and treatment strategies

Psychiatric Quarterly

Volumn 70, Issue 4, 1999, Pages 313-331

  Phillips, Katharine A ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BUTLER HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANXIETY; BODY DYSMORPHIC DISORDER; COMORBIDITY; COMPULSION; CONFERENCE PAPER; CONSCIOUSNESS DISORDER; DELUSION; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE;

EID: 0032703036     PISSN: 00332720     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022090200057     Document Type: Conference Paper

References (45)

1. Morselli E: Sulla dismorfofobia e sulla tafefobia. Bolletinno della R accademia di Genova 6:110-119, 1891.
2. Phillips KA: Body dysmorphic disorder: the distress of imagined ugliness. American Journal of Psychiatry 148:1138-1149, 1991.
3. Phillips KA, McElroy SL, Keck PE Jr, et al: Body dysmorphic disorder: 30 cases of imagined ugliness. American Journal of Psychiatry 150:302-308, 1993.
4. Phillips KA: The Broken Mirror: Understanding and Treating Body Dysmorphic Disorder. New York, Oxford University Press, 1996.
5. Veale D, Boocock A, Gournay K, et al: Body dysmorphic disorder: a survey of fiftycases. British Journal of Psychiatry 169:196-201, 1996.
6. Hollander E, Cohen LJ, Simeon D: Body dysmorphic disorder. Psychiatric Annals 23: 359-364, 1993.
7. Perugi G, Akiskal HS, Giannotti D, et al: Gender-related differences in body dysmorphic disorder (dysmorphophobia). Journal of Nervous and Mental Disease 185:578-582, 1997.
8. Pope HG Jr, Gruber AJ, Choi P, et al: Muscle dysmorphia: an underrecognized form of body dysmorphic disorder. Psychosomatics 38:548-557, 1997.
9. Phillips KA, McElroy SL, Keck PE Jr, et al: A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacology Bulletin 30: 179-186, 1994.
10. O'Sullivan RL, Phillips KA, Keuthen NJ, et al: Near fatal skin picking from delusional body dysmorphic disorder responsive to fluvoxamine. Psychosomatics 40:79-81, 1999.
11. DeMarco LM, Li LC, Phillips KA, et al: Perceived stress in body dysmorphic disorder. Journal of Nervous and Mental Disease 186:724-726, 1998.
12. Phillips KA, Diaz S: Gender differences in body dysmorphic disorder. Journal of Nervous and Mental Disease 185:570-577, 1997.
13. Albertini RS, Phillips KA: 33 cases of body dysmorphic disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 38:453-459, 1999.
14. Cotterill JA, Cunliffe WJ: Suicide in dermatological patients. British Journal of Dermatology 137:246-250, 1997.
15. Hay GG: Dysmorphophobia. British Journal of Psychiatry 116:399-406, 1970.
16. Cotterill JA: Dermatological non-disease: a common and potentially fatal disturbance of cutaneous body image. British Journal of Dermatology 104:611-619, 1981.
17. Hardy GE, Cotterill JA: A study of depression and obsessionality in dysmorphophobic and psoriatic patients. British Journal of Psychiatry 140:19-22, 1987.
18. Du Fort GG, Newman SC, Bland RC: Psychiatric comorbidity and treatment seeking: sources of selection bias in the study of clinical populations. Journal of Nervous and Mental Disease 181:467-474, 1993.
19. Brawman-Mintzer O, Lydiard RB, Phillips KA, et al: Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. American Journal of Psychiatry 152:1665-1667, 1995.
20. Phillips KA, Atala KD, Pope HG: Diagnostic instruments for body dysmorphic disorder. New Research Program and Abstracts, American Psychiatric Association 148th Annual Meeting. Miami: American Psychiatric Association, 1995:157.
21. Nierenberg AA, Phillips KA, Kaji J, et al: Body dysmorphic disorder is comorbid with major depression. New Research Program and Abstracts, American Psychiatric Association 148th Annual Meeting. Miami: American Psychiatric Association, 1995:154.
22. Phillips KA, Nierenberg AA, Brendel G, et al: Prevalence and clinical features of body dysmorphic disorder in atypical major depression. Journal of Nervous and Mental Disease 184:125-129, 1996.
23. Perugi G, Akiskal HS, Lattanzi L, et al: The high prevalence of "soft" bipolar (II) features in atypical depression. Comprehensive Psychiatry 39:63-71, 1998.
24. Soriano JL, O'Sullivan RL, Baer L, et al: Trichotillomania and self-esteem: a survey of 62 female hair pullers. Journal of Clinical Psychiatry 57:77-82, 1996.
25. Rosen JC, Ramirez E: A comparison of eating disorders and body dysmorphic disorder on body image and psychological adjustment. Journal of Psychosomatic Research 44:441-449, 1998.
26. Phillips KA, Dwight MM, McElroy SL: Efficacy and safety of fluvoxamine in body dysmorphic disorder. Journal of Clinical Psychiatry 59:165-171, 1998.
27. Lyons MJ, Tyrer P, Gunderson J, et al: Heuristic models of comorbidity of axis I and axis II disorders. Journal of Personality Disorders 11:260-269, 1997.
28. Phillips KA, McElroy SL, Hudson JI, et al: Body dysmorphic disorder: an obsessive compulsive spectrum disorder, a form of affective spectrum disorder, or both? Journal of Clinical Psychiatry 56(S):41-52, 1995.
29. Hudson JI, Pope HG Jr: Affective spectrum disorder: does antidepressant response identify a family disorders with a common pathophysiology? American Journal of Psychiatry 147:553-564, 1990.
30. Phillips KA, Gunderson CG, Mallya G, et al: A comparison study of body dysmorphic disorder and obsessive compulsive disorder. Journal of Clinical Psychiatry 59:568-575, 1998.
31. Hollander E, Phillips KA: Body image and experience disorders: body dysmorphic and depersonalization disorders, in Obsessive Compulsive-Related Disorders. Edited by Hollander E. Washington, DC, American Psychiatric Press Inc, 1992.
32. Fukuda O: Statistical analysis of dysmorphophobia in out-patient clinic. Japanese Journal of Plastic and Reconstructive Surgery 20:569-577, 1997.
33. Munro A. Delusional Hypochondriasis. Toronto, Clarke Institute of Psychiatry Monograph Series #5, 1982.
34. Hollander E, Liebowitz MR, Winchel R, et al: Treatment of body-dysmorphic disorder with serotonin reuptake blockers. American Journal of Psychiatry 146:768-770, 1989.
35. Phillips KA: Body dysmorphic disorder: diagnosis and treatment of imagined ugliness. Journal of Clinical Psychiatry 57(S):61-64, 1996.
36. Perugi G, Giannotti D, Di Vaio S, et al: Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). International Clinical Psychopharmacology 11:247-254, 1996.
37. Hollander E, Cohen L, Simeon D, et al: Fluvoxamine treatment of body dysmorphic disorder (letter). Journal of Clinical Psychopharmacology 14:75-77, 1994.
38. Neziroglu FA, Yaryura-Tobias JA: Exposure, response prevention, and cognitive therapy in the treatment of body dysmorphic disorder. Behavior Therapy 24:431-438, 1993.
39. Wilhelm S, Otto MW, Lohr B, et al: Cognitive behavior group therapy for body dysmorphic disorder: a case series. Behaviour Research and Therapy 37:71-75, 1999.
40. Rosen JC, Reiter J, Orosan P: Cognitive-behavioral body image therapy for body dysmorphic disorder. Journal of Consulting and Clinical Psychology 63:263-269, 1995.
41. Veale D, Gournay K, Dryden W, et al: Body dysmorphic disorder: a cognitive behavioural model and pilot randomized controlled trial. Behavior Research and Therapeutics 34:717-729, 1996.
42. McKay D, Todaro J, Neziroglu F, et al: Body dysmorphic disorder: a preliminary evaluation of treatment and maintenance using exposure and response prevention. Behaviour Research and Therapy 35:67-70, 1997.
43. Phillips KA, McElroy SL: Treatment response of depression in patients with body dysmorphic disorder. New Clinical Drug Evaluation Unit Program (NCDEU) 38th Annual Meeting Abstracts of Poster Presentations. Boca Raton: National Institute of Mental Health, 1998:146.
44. Phillips KA: An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorder. Psychopharmacology Bulletin 2:175-180, 1996.
45. Zimmerman M, Mattia JI: Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates. Comprehensive Psychiatry 39:265-270, 1998.